9.64% +0.0174

Tonix Pharmaceuticals Holding Corp (TNXP)

Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten

Tonix Pharmaceuticals Holding Corp (TNXP)

Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.12% - MSN

Why Tonix Pharmaceuticals (TNXP) Shares Are Plummeting - MSN

Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase - Yahoo Finance

Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights - GlobeNewswire

Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights - 13.05.2024 - wallstreet:online

Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com - Defense World

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) to Post Q2 2024 Earnings of ($0.29) Per Share, Zacks Small ... - Defense World

TNXP: Approval of First New Fibromyalgia Drug in 15 Years Possible in 2025… - Yahoo Finance

StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) - Defense World

Noble Capital slashes Tonix Pharma share target on future sales outlook - Investing.com Canada

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On? - Tonix Pharmaceuticals (NAS - Benzinga

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering

Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated - Tonix Pharmaceuticals (NASDAQ:TNXP) - Benzinga

Tonix's TNX-2900 gains FDA rare pediatric disease tag - Investing.com

3 Mind-Blowing Stocks That Could Turn $1000 Into $1 Million - InvestorPlace

Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin ... - Yahoo Finance

Tonix Pharma Readies for Tonmya™ U.S. Launch and Production - TipRanks.com - TipRanks

Tonmya advances towards FDA submission for fibromyalgia By Investing.com - Investing.com

Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024

Tonix to market migraine treatments as it gears for new drug launch - Investing.com

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring

TNXP: Tonmya™ May Launch Alongside Another New Fibromyalgia Treatment… - Yahoo Finance

Tonmya shows promise in Phase 3 fibromyalgia study By Investing.com - Investing.com

Sublingual Bedtime Treatment Aids Sleep and Reduces PTSD in Veterans - Sleep Review

Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy

Tonix's PTSD treatment shows promise in early study - Investing.com

Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya ... - GlobeNewswire

Tonix Pharma Advances with Promising TNX-1500 Studies - TipRanks.com - TipRanks

Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified ... - GlobeNewswire

Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L ... - Yahoo Finance

Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to ... - Yahoo Finance

Drug Candidate Helps Fibromyalgia Pain by Boosting Sleep Quality - Sleep Review

3 Top Penny Stocks for 5000% Upside in 2024 and Beyond - Markets Insider

Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference

Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor Conference - Yahoo Finance

Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032 - GlobeNewswire

Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024

Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA ... - GlobeNewswire

Tonix Pharmaceuticals Announces Engagement of Rho as CRO to Support Submission of New Drug Application to the ... - Yahoo Finance

Tonix's PTSD drug cleared for phase 2 trauma trial - Investing.com

Tonix Pharma Discloses COPCs Linked to Long COVID Risk - TipRanks.com - TipRanks

Tonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID

Tonix Pharma Announces FDA's Conditional Acceptance of Tonmya™ - TipRanks.com - TipRanks

Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for the Management of Fibromyalgia

Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya™ as Trade Name for TNX-102 SL for the ... - GlobeNewswire

Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P.

Tonix Pharmaceuticals Announces KOL Webinar to Discuss Positive Phase 3 Fibromyalgia Data, Sponsored by A.G.P. - GlobeNewswire

TNXP: Positive Results for Phase 3 RESILIENT Trial Sets Up NDA Filing in 2H24… - Yahoo Finance

Ähnlich wie TNXP